Debela Ejeta | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Debela Ejeta
Ambo University

Debela Ejeta
Affiliation Ambo University
Country Ethiopia
Scopus ID 57823056300
Documents 3
Citations 638
h-index 2
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0009-0008-2289-0397

Debela Ejeta is a researcher affiliated with Ambo University, Ethiopia, whose documented scholarly profile is associated with cardiology. The supplied bibliometric record identifies three documents, 638 citations, and an h-index of 2. Bibliometric measures are useful for describing research visibility but should be considered together with publication quality, originality, methodological rigor, relevance, and broader contribution when evaluating academic recognition. [1]

Abstract

Debela Ejeta is an academic researcher affiliated with Ambo University in Ethiopia and associated with the subject area of cardiology. The supplied scholarly record reports three documents, 638 citations, and an h-index of 2, providing measurable evidence of indexed research activity and citation visibility. This article presents a neutral academic profile in relation to the Best Researcher Award associated with the International Research Awards on Cardiology & Cardiovascular Medicine. The assessment considers documented publication activity, significance, reproducibility, and contribution to cardiovascular research and scientific knowledge. [1]

Keywords

Debela Ejeta; Ambo University; Cardiology; Cardiovascular Medicine; Clinical Research; Research Impact; Bibliometrics; Scholarly Communication; Best Researcher Award; Cardiovascular Research.

Introduction

Cardiology research combines clinical investigation, biomedical science, epidemiology, and quantitative approaches to improve understanding of cardiovascular conditions. Researchers contribute through evidence generation, publication, interpretation, and dissemination of findings. Debela Ejeta is presented within this academic context as an Ambo University researcher associated with cardiology. Established research-metrics guidance recommends that quantitative indicators be interpreted carefully and alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Research Profile

Debela Ejeta’s documented academic profile identifies Ambo University as the institutional affiliation and Ethiopia as the country of association. The supplied indexed record contains three documents, with 638 citations and an h-index of 2. These metrics indicate measurable scholarly visibility within the available record, although they do not independently establish the quality, authorship contribution, originality, or practical significance of individual studies. [1]

Research Contributions

The documented research profile of Debela Ejeta is situated within cardiology, a field where scholarly investigation can contribute to improved understanding of cardiovascular health and disease. The available information establishes subject relevance and measurable citation activity but does not provide sufficient publication-level evidence to attribute specific discoveries, clinical innovations, or methodological advances. Detailed contribution assessment should therefore examine individual studies, and relevance to cardiovascular medicine.

Publications

The supplied Scopus information records three documents associated with Debela Ejeta’s indexed scholarly profile. Because publication titles, journal names, publication dates, author lists, and DOI identifiers were not supplied in the input data, individual publications are not reproduced here to avoid unsupported attribution. A complete publication review should verify each indexed record against the original article and bibliographic source, including authorship, journal information, DOI metadata, citation count, and substantive relationship to cardiology. [1]

Research Impact

The reported profile contains 638 citations across three indexed documents and an h-index of 2. Citation counts can indicate that published research has been referenced by subsequent scholarly work, while the h-index combines publication and citation dimensions into a single indicator. Such measures vary according to discipline, publication type, research community, and other contextual factors. [2]

Award Suitability

Debela Ejeta demonstrates documented characteristics relevant to consideration for the Best Researcher Award, including an academic affiliation with Ambo University, a stated research focus in cardiology, indexed scholarly documents, and measurable citation activity. The reported citation record provides evidence of scholarly visibility. Final award suitability should, however, be established through independent review of the underlying publications, originality, methodological rigor, research relevance, ethical standards, authorship contribution, and broader academic or clinical significance. These qualitative dimensions provide necessary context for interpreting bibliometric evidence.

Conclusion

Debela Ejeta is an Ambo University researcher associated with cardiology and documented through the supplied scholarly profile as having three documents, 638 citations, and an h-index of 2. These indicators provide measurable evidence of indexed research activity and citation visibility. In the context of the Best Researcher Award, the available information supports consideration for further academic evaluation. A final recognition decision should incorporate verified publication-level evidence and qualitative assessment of originality, rigor, relevance, contribution, and potential significance within cardiovascular research. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Debela Ejeta, Author ID 57823056300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57823056300
  2. Journal article (2026. ) Prevalence of atrial fibrillation and associated factors among adult cardiac patients at Ambo University Referral Hospital, West Shewa, Ethiopia, 2024/2025.
    https://doi.org/10.1016/j.ahjo.2026.100832
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Worku Tassew | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Worku Tassew
Teda Health Science College, Ethiopia

Worku Tassew
Affiliation Teda Health Science College
Country Ethiopia
Scopus ID 57258929800
Documents 57
Citations 111
h-index 6
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-7952-1738

Worku Tassew is a researcher affiliated with Teda Health Science College in Ethiopia whose scholarly record is associated with cardiovascular research. The researcher has a documented Scopus profile containing 57 documents, 111 citations, and an h-index of 6. These bibliometric indicators provide a quantitative overview of research productivity and citation impact within the indexed scholarly literature. [1]

Abstract

Worku Tassew is a researcher affiliated with Teda Health Science College, Ethiopia, with scholarly activity positioned within cardiovascular research. Available bibliometric information identifies 57 indexed documents, 111 citations, and an h-index of 6, providing measurable indicators of publication productivity and citation influence. The researcher’s subject classification in Cardiovascular Researches places the academic record within a field concerned with cardiovascular health, disease mechanisms, prevention, diagnosis, treatment, and related clinical research. This profile is considered in relation to the Best Researcher Award under the International Research Awards on Cardiology & Cardiovascular Medicine, using documented scholarly indicators and research relevance. [1]

Keywords

Worku Tassew; Cardiovascular Researches; Cardiology; Cardiovascular Medicine; Research Productivity; Citation Impact; Scholarly Publications; Bibliometrics; Teda Health Science College; Best Researcher Award.

Introduction

Cardiovascular research encompasses a broad scientific and clinical field addressing diseases and conditions affecting the heart and circulatory system. Contemporary cardiovascular scholarship includes epidemiology, prevention, diagnostics, therapeutic interventions, rehabilitation, cardiovascular risk factors, and translational research. Bibliometric measures such as documents, citations, and h-index are commonly used to describe aspects of scholarly productivity and citation influence, although they do not independently determine research quality. [2]

Research Profile

The available Scopus information records 57 documents associated with Worku Tassew, together receiving 111 citations and producing an h-index of 6. The document count indicates sustained indexed publication activity, while citations provide an observable measure of how published research has been referenced within subsequent scholarly literature. The stated subject area, Cardiovascular Researches, establishes the principal scholarly relevance of the profile to the International Research Awards on Cardiology & Cardiovascular Medicine. ORCID provides a persistent identifier that can assist in distinguishing a researcher from individuals with similar names and in connecting scholarly contributions across research systems. [3]

Research Contributions

For award assessment, research contributions can therefore be considered in conjunction with the researcher’s publication record, citation performance, subject alignment, and supporting evidence submitted for evaluation. Such a combined assessment provides a more balanced interpretation than reliance on any single bibliometric indicator. [4]

Publications

The Scopus record associated with Worku Tassew contains 57 indexed documents. This publication volume represents the documented scholarly output available through the supplied researcher profile. Publication counts can provide a useful indicator of research activity, but comparisons between researchers should account for differences in discipline, career stage, collaboration patterns, publication practices, and citation behavior. [1]A detailed assessment of individual publications should examine article subject matter, journal quality, study design, authorship role, methodological contribution, and relevance to cardiovascular research. Where individual publication records and DOI information are available, those primary records provide the appropriate basis for verifying publication details and research outputs.

Research Impact

The profile records 111 citations across 57 documents, with an h-index of 6. These figures indicate that the researcher’s publications have received measurable attention within the indexed scholarly literature. Citation counts can reflect research visibility and subsequent scholarly use, although citation behavior varies substantially among disciplines and publication types. Consequently, citation indicators are best interpreted as quantitative evidence rather than as a complete measure of scientific or clinical impact. [2]

Award Suitability

The Best Researcher Award profile is relevant to the International Research Awards on Cardiology & Cardiovascular Medicine because the supplied subject classification is Cardiovascular Researches and the documented publication record demonstrates indexed scholarly activity. The 57 documents, 111 citations, and h-index of 6 provide quantitative evidence that may support consideration of research productivity and scholarly influence. [1]Final award evaluation should consider the complete nomination materials, including the quality and relevance of publications, originality of research, methodological strength, documented contributions, research significance, and alignment with the award criteria. Bibliometric indicators can complement this assessment but should not be treated as the sole determinant of recognition.

Conclusion

Worku Tassew’s documented academic profile reflects research activity associated with Cardiovascular Researches at Teda Health Science College in Ethiopia. The available Scopus indicators of 57 documents, 111 citations, and an h-index of 6 provide a quantitative foundation for reviewing publication productivity and citation influence. [1] In the context of the Best Researcher Award, these indicators can be considered alongside the substantive quality, relevance, originality, and significance of the researcher’s cardiovascular research contributions.

References

  1. Elsevier. (n.d.). Scopus author details: Worku Tassew, Author ID 57258929800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57258929800
  2. Journal article. (2026). Incidence and predictors of tuberculosis among adult diabetes mellitus patients in western Amhara comprehensive specialized hospitals, northwest Ethiopia. A multicenter retrospective follow-up study.
    https://doi.org/10.1177/22799036261451534
  3. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.
    https://orcid.org/0000-0001-7952-1738
  4. Journal article. (2026). Companionship care and associated factors among childbirth women in Ethiopia: a systematic review and meta-analysis.
    https://doi.org/10.1177/26334941261434846
  5. World Health Organization. (2023). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Yusheng Liu | Interventional Cardiology | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

Prof. Yusheng Liu | Interventional Cardiology | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile:

Scopus

🩺 PROF. YUSHENG LIU – A PIONEER IN HEART FAILURE & ECHOCARDIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

Prof. Yusheng Liu began his illustrious academic journey in Clinical Medicine at Taishan Medical School (now The First Medical University of Shandong), earning his Bachelor’s degree (1995–2000). His quest for deeper knowledge led him to pursue a Master’s degree in Internal Medicine with a focus on Cardiovascular Disease at Shandong University School of Medicine (2004–2007), followed by an M.D. in Cardiovascular Medicine (2010–2013) from the same institution.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Since July 2000, Prof. Liu has served at the Second Hospital of Shandong University, currently holding the title of Deputy Chief Physician of Cardiovascular Medicine, Associate Professor, and Doctoral Supervisor. He also leads the Cardiac Care Unit (CCU) and plays a pivotal role in guiding the next generation of clinicians as a Master’s tutor.

His career also extends into professional societies, where he holds several leadership roles, including:

  • Executive Director, China Ultrasonic Medical Engineering Society (Echocardiography Division)

  • Vice Chairman, Shandong Ultrasound in Medicine Engineering Institute

  • Youth Leader, Shandong Medical Health System

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON INTERVENTIONAL CARDIOLOGY

Prof. Liu has dedicated his research to heart failure, echocardiography, coronary artery disease, and atherosclerosis. He has:

  • Led or contributed to multiple National Key Projects such as 973, 863, and the National Natural Science Foundation

  • Chaired international collaborations like the Macau SAR Science & Technology Fund

  • Focused heavily on biomarker-based diagnostics, ventricular function in diabetes, and plaque stability in coronary syndromes

His projects have bridged clinical and basic science, contributing to real-world patient improvements and high-impact academic knowledge.

🏆 IMPACT AND INFLUENCE

Prof. Liu’s work has been nationally and internationally recognized:

  • Two-time winner of National Science and Technology Progress Award

  • Recipient of multiple provincial awards including 4 second-place and 6 third-place Science & Tech Awards

  • Frequent keynote speaker at conferences such as:

    • 24th Great Wall International Cardiology Conference

    • 12th National Echo Cardiac Conference

    • 2016 Pharmacology & Ethnopharmacology Conference, Chicago, USA

He is also involved in clinical ethics, oncology cardiology, heart rehabilitation, and hypertension professional committees.

📚 ACADEMIC CITATIONS AND MEMBERSHIPS

Prof. Liu is a proud member of:

  • American Society of Echocardiography (ASE)

  • China Ultrasound Medical Engineering Society (Permanent Member)

  • Various Shandong Medical Associations across cardiology, ethics, and disaster medicine

His publications and research are cited in numerous national and international cardiovascular journals and conferences, further amplifying his impact on the global stage.

🧪 SCIENTIFIC PROJECTS (SELECTED)

Some of the noteworthy research projects under his leadership include:

  1. Huatong-Guokang Medical Scientific Research Project – Ministry of Education (2023)

  2. Clinical Elite Scientist Programme (2018)

  3. National Key R&D Plan (2022YFC3502100)

  4. Lipoprotein-Associated Phospholipase A2 and Plaque Stability (2014)

  5. JNK Pathway and Atherosclerosis Mechanism (2013)

  6. DPP-4 Inhibitors and Ventricular Function in Diabetic Patients (2013)

🏅 AWARDS AND HONORS

Prof. Liu has received:

  • Lecture Honorary Certificate – Pharmacology & Ethnopharmacology 2016

  • Shandong Soft Science Excellence Award

  • Outstanding Teaching Certificate – Weifang University (2016)

  • Advanced Medical Worker Honor – Phoenix Media

  • Scholarships from Shandong University and affiliated hospitals

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Yusheng Liu stands as a leading voice in the evolution of cardiovascular care in China and beyond. His multidisciplinary influence spans clinical excellence, scientific innovation, academic mentorship, and global collaboration.

In the years to come, his focus on integrating precision medicine, biomarkers, and advanced imaging will continue shaping the future of heart failure diagnostics, ultrasound cardiology, and clinical translational research. With a legacy rooted in innovation and education, he continues to inspire and uplift the cardiovascular medicine community.

📑 NOTABLE PUBLICATION

"Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome"

Authors: Xuguang Zhang, Zhiwei Huang, Xin Wang, Han Hao, Dali Fan, Martin Cadeiras, Yusheng Liu
Journal: Catheterization and Cardiovascular Interventions
Year: 2025

 

Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Ruoxi Zhang | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Ruoxi Zhang | Cardiology | Best Researcher Award

Dr. Ruoxi Zhang, Harbin Medical University, China.

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. He earned his doctorate from Harbin Medical University and has over a decade of clinical experience at renowned institutions, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to advancing medical research. His extensive publications focus on artificial intelligence in cardiology, interventional techniques, and diagnostic innovations. Dr. Zhang’s dedication to medical science and patient care underscores his significant contributions to the field of cardiovascular research.

Author Profile

Suitability for Best Researcher Award

Dr. Ruoxi Zhang is a highly accomplished physician and researcher in cardiovascular medicine, with over a decade of experience in clinical practice and academic research. He holds a Doctorate in Clinical Medicine from Harbin Medical University and has served in prestigious hospitals, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital at Shanghai Jiao Tong University School of Medicine.

Education:

Dr. Ruoxi Zhang has a strong academic foundation in clinical and internal medicine. He earned his Doctorate in Clinical Medicine from Harbin Medical University (2013–2016) and a Master’s degree in Internal Medicine from the same institution (2007–2010). His medical journey began with a Bachelor’s degree in Clinical Medicine from Qiqihar Medical University (2002–2007). His advanced education equipped him with extensive knowledge in diagnosing and treating complex medical conditions. Through rigorous academic training and research, Dr. Zhang has developed a deep expertise in cardiovascular medicine, laying the groundwork for his distinguished career as a physician and researcher in the medical field.

Professional Experience:

Dr. Ruoxi Zhang has over a decade of experience in clinical medicine, specializing in cardiology. He began his medical career as a physician at The Second Affiliated Hospital of Harbin Medical University, where he served for ten years, gaining expertise in patient care and advanced medical procedures. He then joined Harbin Yinghua Hospital, further refining his skills in cardiovascular treatment. Currently, he is a physician at Suzhou Kowloon Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His extensive clinical experience, combined with his research contributions, underscores his commitment to advancing cardiovascular medicine and improving patient outcomes.

Research Interests:

Dr. Ruoxi Zhang’s research interests focus on cardiovascular medicine, interventional cardiology, and advanced imaging techniques for diagnosing and treating heart diseases. He is particularly engaged in artificial intelligence applications in intracardiac echocardiography and computed tomography-derived fractional flow reserve to enhance diagnostic precision. His work explores innovative interventional strategies for patients with acute coronary syndromes, myocardial infarction, and diabetes-related cardiovascular conditions. Additionally, he investigates endothelialization processes, stent implantation techniques, and platelet aggregation in post-percutaneous coronary intervention patients. Dr. Zhang is committed to integrating novel technologies into clinical practice to improve cardiovascular outcomes and patient care.

Recognition and Impact:

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to the advancement of medical research. With numerous high-impact publications in esteemed journals, his work on artificial intelligence in echocardiography and interventional cardiology has influenced clinical practices. His research has enhanced diagnostic precision and treatment efficacy, earning recognition from the medical community. Through his dedication to innovation and patient-centered care, Dr. Zhang has established himself as a leading expert, significantly impacting the field of cardiovascular research.

Citations:

Citations – 576
h-index – 14
i10-index – 19

Conclusion:

Dr. Ruoxi Zhang’s strong academic background, extensive professional experience, editorial roles, and prolific research contributions make him a highly suitable candidate for the Best Researcher Award. His work has significantly impacted cardiovascular medicine, and his dedication to advancing medical research sets him apart as an outstanding scholar and clinician.

 Top Notable Publications

Colchicine alleviates cholesterol crystal‐induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway

Author(s): M Yang, H Lv, Q Liu, L Zhang, R Zhang, X Huang, X Wang, B Han, S Hou, …

Journal: Oxidative Medicine and Cellular Longevity

Year: 2020 📅

Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow

Author(s): D Liu, H Lv, Q Liu, Y Sun, S Hou, L Zhang, M Yang, B Han, G Wang, …

Journal: Journal of Translational Medicine

Year: 2019 📰

C1q/TNF‐related protein 9 inhibits the cholesterol‐induced vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase

Author(s): Q Liu, H Zhang, J Lin, R Zhang, S Chen, W Liu, M Sun, W Du, J Hou, B Yu

Journal: Journal of Cellular and Molecular Medicine

Year: 2017 🧬

C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways

Author(s): J Lin, Q Liu, H Zhang, X Huang, R Zhang, S Chen, X Wang, B Yu, J Hou

Journal: Oncotarget

Year: 2017 💡

Identification of biomarkers for unstable angina by plasma metabolomic profiling

Author(s): M Sun, X Gao, D Zhang, C Ke, Y Hou, L Fan, R Zhang, H Liu, K Li, B Yu

Journal: Molecular BioSystems

Year: 2013 🔬

Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction

Author(s): Z Jiang, R Zhang, M Sun, Q Liu, S Wang, W Wang, Q Zhao, H Zhang, …

Journal: Canadian Journal of Cardiology

Year: 2018 💓

Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention

Author(s): Q Zhao, R Zhang, J Hou, B Yu

Journal: Acta Cardiologica Sinica

Year: 2018 ❤️

C1q/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPKα/KLF4 signaling pathway

Author(s): G Wang, B Han, R Zhang, Q Liu, X Wang, X Huang, D Liu, W Qiao, …

Journal: Frontiers in Pharmacology

Year: 2021 💪

Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection

Author(s): R Zhang, S Chen, H Zhang, W Wang, J Xing, Y Wang, B Yu, J Hou

Journal: International Heart Journal

Year: 2016 ❤️

Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study

Author(s): R Zhang, S Chen, H Zhang, Q Liu, J Xing, Q Zhao, Y Wang, B Yu, J Hou

Journal: Scientific Reports

Year: 2016 🐇

Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis

Author(s): H Zhang, Q Liu, JL Lin, Y Wang, RX Zhang, JB Hou, B Yu

Journal: Biomolecules & Therapeutics

Year: 2018 💉

Fragmented QRS complex is a prognostic marker of microvascular reperfusion and changes in LV function occur in patients with ST elevation myocardial infarction who underwent …

Author(s): R Zhang, S Chen, Q Zhao, M Sun, B Yu, J Hou

Journal: Experimental and Therapeutic Medicine

Year: 2017 🏥

Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation

Author(s): X Liu, R Zhang, J Hou, J Wu, M Zhang, S Fang, X Wang, X Huang, J Tian, …

Journal: Clinical Science

Year: 2019 💉

Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3‐vessel optical coherence tomography study

Author(s): D Zhang, R Zhang, N Wang, L Lin, B Yu

Journal: BioMed Research International

Year: 2018 🧪

Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice

Author(s): Y Xu, Y Wang, J Liu, W Cao, L Li, H Du, E Zhan, R Zhang, H Liu, M Xu, …

Journal: Journal of Molecular Endocrinology

Year: 2019 🐁

Yumei Li | Pediatric Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof.Yumei Li | Pediatric Cardiology | Best Researcher Award

Prof. Yumei Li,  The First Hospital of Jilin University,  China.

Yumei Li is the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. A renowned leader in Pediatric Critical Care Medicine, she founded the largest and most advanced pediatric critical care unit in Jilin Province. With over 31 years of experience, Professor Li has led 50 research projects and published 130 papers, including 45 SCI-indexed articles. She has mentored doctoral students, contributed to eight key textbooks, and secured nearly 4 million yuan in research funding. Her work in pediatric liver transplantation and life support technology has driven innovation and saved countless lives.

Author Profile:

Scopus Profile

Summary of Suitability for Best Researcher Award

Dr. Yumei Li, Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University, is an exemplary candidate for the Best Researcher Award. With over 31 years of experience, Dr. Li has made pioneering contributions in pediatric critical care, particularly in pediatric liver transplantation and extracorporeal life support technologies, transforming clinical care standards in Jilin Province.Her impressive research portfolio includes leading 50 national and provincial projects, securing nearly 4 million yuan in research funding. Dr. Li has published 130 research papers, with 45 indexed in SCI journals, reflecting her significant global impact. Additionally, her academic influence is demonstrated through 16 teaching grants, authorship of 8 major textbooks, and supervision of 21 research scholars (15 graduated, 6 ongoing).

🎓 Education:

Yumei Li holds a doctoral degree in Pediatrics, showcasing her strong academic foundation and commitment to advancing medical knowledge. As a professor and doctoral supervisor, she has dedicated nearly 30 years to pediatric education and research. Her expertise spans pediatric critical care, with significant contributions to clinical advancements and medical education. She has played a key role in developing pediatric textbooks and teaching materials, serving as an editorial board member for several publications. Her passion for education and mentorship has shaped future pediatric specialists, solidifying her reputation as a distinguished educator and leader in the field of Pediatrics.

💼 Professional Experience:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation

🌍Research Contributions:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation.

🥇Award and Honors:

Yumei Li has received 16 awards and honors recognizing her outstanding contributions to pediatric critical care and medical research. As the founder of the Pediatric Critical Care Medicine Department in Jilin Province, she has been honored for advancing pediatric liver transplantation and extracorporeal life support technology. Her leadership and dedication have earned her numerous accolades for excellence in clinical practice, teaching, and research. Professor Li’s impactful contributions include leading 50 research projects and publishing 130 papers, which have significantly influenced pediatric healthcare. These achievements highlight her commitment to innovation, education, and improving patient outcomes, solidifying her reputation as a distinguished medical professional.

Conclusion:

Professor Yumei Li has made outstanding contributions to the field of Pediatric Critical Care Medicine through her exceptional leadership, research, and clinical expertise. With over 31 years of experience, she has established the largest pediatric critical care unit in Jilin Province, significantly advancing pediatric liver transplantation and extracorporeal life support technologies. Her impressive research portfolio, including 50 funded projects and 130 publications with 45 SCI-indexed papers, reflects her commitment to innovation and academic excellence. Professor Li’s dedication to education, mentorship, and technological advancements highlights her as a pioneering figure, making her a deserving candidate for the Best Researcher Award.

📚Publication Top Notes:

📄 “Comprehensive review of indicators and techniques for optical mapping of intracellular calcium ions” – Cerebral Cortex, 2024, 34(8), bhae346 | Cited: 0

🧒 “Children with severe neurological symptoms associated with SARS-CoV-2 infection during Omicron pandemic in China” – Pediatric Research, 2024, 95(4), pp. 1088–1094 | Cited: 0

🏥 “Association between BNP and all-cause mortality in critically ill children: a cohort study” – Pediatric Research, 2024 | Cited: 0

🦠 “Biliary atresia: the role of gut microbiome, and microbial metabolites” – Frontiers in Cellular and Infection Microbiology, 2024, 14, 1411843 | Cited: 0

🍊 “Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications” – Frontiers in Pharmacology, 2024, 15, 1354809 | Cited: 4

🚨 “Demographics and Clinical Characteristics Assessment of Severe Acute Toxic Ingestions in Pediatric Patients: A Single-Center Study in Jilin Province of China” – Pediatric Emergency Care, 2023, 39(12), pp. 957–962 | Cited: 0

🧪 “Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor” – Materials Today Bio, 2023, 23, 100796 | Cited: 6

🧠 “Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature” – Acta Neurologica Belgica, 2023, 123(5), pp. 1663–1678 | Cited: 0

⚛️ “One-Component Artificial Gustatory System Based on Hydrogen-Bond Organic Framework for Discrimination of Versatile Analytes” – Advanced Functional Materials, 2023, 33(24), 2300091 | Cited: 22

🔄 “Therapeutic plasma exchange in anti-N-methyl-D-aspartate receptor encephalitis” – Therapeutic Apheresis and Dialysis, 2023, 27(2), pp. 197–206 | Cited: 0

Zaid Al jebaje | Interventional Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

🎓Current Position:

Dr. Zaid Al-Jebaje is currently engaged in his role at Toledo Cardiology Consultants since July 2024. Prior to this, he completed his fellowship in complex, high-risk, and indicated percutaneous interventions at the Henry Ford Health System in Detroit, Michigan. This fellowship emphasized intricate coronary and peripheral interventions, chronic total occlusions, and mechanical support, reflecting his advanced skill set in interventional cardiology. His education and clinical training have equipped him with a robust foundation for delivering high-quality cardiovascular care.

📚Academic Background:

Dr. Al-Jebaje earned his MBChB from the University of Baghdad College of Medicine in Iraq (2006-2012). He completed his Internal Medicine Residency at the University at Buffalo – Catholic Health System (2016-2019) and subsequently pursued a Cardiovascular Fellowship at the University of Rochester – Strong Memorial Hospital. He further specialized with an Interventional Cardiology Fellowship at the Henry Ford Health System (2019-2023). His extensive education has provided him with the theoretical knowledge and practical skills necessary to excel in his field

📝Publication Achievements:

Dr. Al-Jebaje has an impressive publication record, contributing to over 16 peer-reviewed articles in prominent medical journals. His research covers a diverse array of topics in cardiology, including innovative techniques in transcatheter aortic valve replacement (TAVR) and the management of cardiac conditions. Some notable publications include:

  1. Outcomes following TAVR in patients with cardiogenic shock (2024) – A systematic review and meta-analysis that highlights significant findings in cardiac intervention.
  2. Retrospective Multicenter Analysis of Intravascular Lithotripsy during imaging-guided interventions, published in the Journal of Society of Cardiovascular Angiography and Intervention (2023).
  3. Liberal versus Conservative Transfusion Strategy for Patients with Acute Myocardial Infarction and Anemia (2023) – This systematic review and meta-analysis provides insights into transfusion practices.

Dr. Al-Jebaje’s dedication to research is further illustrated by his involvement in ongoing clinical trials and investigations, continually striving to advance the field of cardiology.

 

🔬Ongoing Research and Research Interests:

Dr. Al-Jebaje’s ongoing research focuses on the efficacy of new interventional techniques and the optimization of patient outcomes in complex cardiac scenarios. His specific interests include:

  • Complex Coronary Interventions: Investigating the best practices for treating patients with chronic total occlusions.
  • Transcatheter Therapies: Exploring advancements in minimally invasive procedures to improve cardiac health.
  • Cardiogenic Shock Management: Evaluating innovative strategies in treating patients experiencing severe heart failure.

These areas reflect his commitment to enhancing the understanding and treatment of cardiovascular diseases, aiming for improved patient care and outcomes.

🤝Professional Associations:

He is an active member of several professional organizations in the field of cardiology, which provide him with platforms for collaboration, continuing education, and sharing advancements in cardiac care. These associations include:

  • American College of Cardiology (ACC)
  • Society for Cardiovascular Angiography and Interventions (SCAI)

These memberships enable him to stay updated on the latest clinical guidelines and innovations in cardiovascular medicine.

🏆Awards and Scholarships 

Throughout his educational journey, Dr. Al-Jebaje has been recognized for his academic excellence and research contributions. While specific awards were not listed, his multiple certifications from the American Board of Interventional Cardiology and other specialties underscore his commitment to lifelong learning and professional development.

🎤Oral Presentations:

He has also delivered several oral presentations at notable conferences, including the SCAISHOCK Conference in Minneapolis (October 2022), where he presented his work on TransCaval LAVA ECMO in cardiogenic shock. Such presentations highlight his role as a thought leader in cardiology, sharing insights and findings with peers in the medical community.

🎓Training & Workshops 

Dr. Al-Jebaje frequently participates in workshops and training sessions to refine his skills and keep abreast of the latest techniques in interventional cardiology. This commitment to ongoing education is essential in a rapidly evolving field like cardiology.

🧪Laboratory Experience and Success Factors:

His extensive publications reflect not only his research proficiency but also his laboratory experience, where he has developed a deep understanding of cardiac physiology and intervention techniques. He is committed to translating his findings into clinical practice, aiming for better outcomes in patient care.

Dr. Al-Jebaje attributes his success to a combination of factors:

  • Dedication to Patient Care: Always prioritizing the well-being of his patients.
  • Continuous Learning: Actively engaging in professional development to enhance his skills.
  • Collaboration: Working alongside leading professionals in cardiology to foster innovation.

🛠️Tasks Completed as a Researcher:

As a researcher, Dr. Al-Jebaje has successfully managed various projects, from clinical trials to meta-analyses, contributing to the advancement of cardiovascular knowledge. His ability to work collaboratively within multidisciplinary teams has led to significant findings that influence clinical practice.

 

🌍Conclusion:

In summary, Dr. Zaid Al-Jebaje stands out as a dedicated interventional cardiologist with a wealth of knowledge and experience in complex cardiovascular interventions. His ongoing research, extensive publication record, and commitment to professional development underscore his influence in the field of cardiology. With a focus on improving patient outcomes and advancing cardiac care, he continues to be a vital contributor to medical science and the healthcare community.

 

Top Notable Publications:
  • Article Title: Galectin-3 Predicts Long-Term Risk of Cerebral Disability and Mortality in Out-of-Hospital Cardiac Arrest Survivors
    Authors: Abdelradi, A., Mosleh, W., Kattel, S., Pokharel, S., Sharma, U.C.
    Journal: Journal of Personalized Medicine
    Year: 2024
    Volume: 14
    Issue: 9
    Article Number: 994
    Citations: 0
  • Article Title: Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions
    Authors: Riley, R.F., Miller, L.E., Davies, R., Dakroub, A., Ali, Z.A.
    Journal: Journal of the Society for Cardiovascular Angiography and Interventions
    Year: 2024
    Volume: 3
    Issue: 2
    Article Number: 101213
    Citations: 1
  • Article Title: Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysis
    Authors: Jabri, A., Ayyad, M., Albandak, M., AlQarqaz, M., Villablanca, P.
    Journal: Cardiovascular Revascularization Medicine
    Year: 2024
    Citations: 0
  • Article Title: Galectin-3 as a risk predictor of mortality in survivors of out-of-hospital cardiac arrest
    Authors: Mosleh, W., Kattel, S., Bhatt, H., Chaudhari, M.R., Sharma, U.C.
    Journal: Circulation: Arrhythmia and Electrophysiology
    Year: 2019
    Volume: 12
    Issue: 10
    Article Number: e007519
    Citations: 6
  • Article Title: Spinal tophaceous gout presenting in a young adult without pain
    Authors: Al-Jebaje, Z., Elibol, J.M., Peters, J., Alameri, A.
    Journal: BMJ Case Reports
    Year: 2018
    Article Number: 224406
    Citations: 5

 

Yu Tian | Cardiac immunology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine
Dr. Yu Tian, Jiangsu University, China

Dr. Yu Tian is a prominent researcher at Jiangsu University, China, specializing in immunology and molecular biology. With a focus on immune cell migration, viral myocarditis, and neuroinflammation, Dr. Tian has contributed significantly to understanding immune responses in cardiovascular and neurological diseases. He has published numerous articles in prestigious journals such as Journal of Leukocyte Biology and International Immunopharmacology, and his research explores therapeutic targets like HMGB1 and IL-22. Dr. Tian’s work plays a critical role in advancing treatment strategies for diseases involving immune system dysfunction and inflammation.

Profile:
Education:

 

Dr. Yu Tian completed his Bachelor’s Degree in Medicine at Qinghai University from September 2011 to June 2016. He then pursued his Master’s and Ph.D. at Jiangsu University, School of Medicine, from September 2016 to September 2022, where he specialized in immunology and molecular biology. His academic journey has laid a strong foundation for his research in immune cell function and disease mechanisms, contributing to his current role as a researcher at Jiangsu University.

Professional Experience:

 

Dr. Yu Tian is currently a researcher at Jiangsu University, School of Life Sciences, specifically within the International Genomics Research Center, a position he has held since December 2022. In this role, he leads a horizontal research project investigating the effects of HMGB1 on immune cells, which commenced in 2023. Additionally, Dr. Tian is actively involved in a National Natural Science Foundation of China (NSFC)-funded project that examines the role of IGF-1 in heart damage following myocardial infarction, scheduled for 2025 to 2027. His work contributes significantly to advancing the understanding of immune mechanisms in cardiovascular health.

 

Research Interest:

 

Dr. Yu Tian’s research interests lie in immunology, specifically investigating the role of HMGB1 in immune cell responses. He focuses on cardiovascular diseases, exploring the mechanisms that contribute to heart damage and myocardial infarction. Additionally, Dr. Tian studies adipose tissue accumulation and its impact on worsening heart conditions, aiming to uncover potential therapeutic targets for improving cardiovascular health. His work seeks to enhance the understanding of immune and metabolic interactions in the context of heart disease.

Conclusion:

Dr. Yu Tian is an accomplished researcher at Jiangsu University, specializing in immunology and cardiovascular diseases. With a solid educational background and a focus on the role of HMGB1 in immune responses, he is dedicated to unraveling the complex mechanisms underlying heart damage and myocardial infarction. His ongoing research projects aim to deepen the understanding of immune cell interactions and metabolic factors that exacerbate cardiovascular conditions. Through his contributions, Dr. Tian is poised to make a significant impact on the field, advancing potential therapeutic strategies for improving heart health and addressing related diseases.

Top Notable Publications:

Yin, P., Su, Z., Shu, X., Dong, Z., Tian, Y. (2024). Role of TREM2 in immune and neurological diseases: Structure, function, and implications. International Immunopharmacology, 143, 113286. 0 citations

Tian, Y., Gong, X., Qin, D., Liu, F., Su, Z. (2023). S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. Journal of Leukocyte Biology, 114(2), 154–163. 7 citations

Tian, Y., Chen, R., Su, Z. (2023). HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease. Cellular and Molecular Neurobiology, 43(1), 47–58. 6 citations

Chen, R., Liu, F., Xia, L., Xu, H., Su, Z. (2022). B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. Journal of Leukocyte Biology, 111(2), 415–425. 1 citation

Cao, Y., Tian, Y., Liu, Y., Su, Z. (2022). Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. International Reviews of Immunology, 41(2), 160–170. 2 citations

Che, Y., Tian, Y., Chen, R., Liu, F., Su, Z. (2021). IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1867(9), 166171. 26 citations

Chen, W., Yao, S., Wan, J., Yao, Y., Zhang, X. (2021). BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. Journal of Controlled Release, 333, 129–138. 45 citations

Li, J., Xia, L., Liu, F., Chen, R., Su, Z. (2021). lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clinical and Translational Medicine, 11(5), e407. 1 citation

Huang, L., Wan, J., Wu, Y., Su, Z., Xu, H. (2021). Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sciences, 270, 119142. 26 citations

Wan, J., Wu, Y., Huang, L., Wang, S., Xu, H. (2021). ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Letters, 502, 34–43. 31 citations

 

 

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.